Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis

被引:16
|
作者
Provenzano, Carlo [1 ]
Marino, Mariapaola [1 ]
Scuderi, Flavia [1 ]
Evoli, Amelia [2 ]
Bartoccioni, Emanuela [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Inst Gen Pathol, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dept Neurosci, I-00168 Rome, Italy
关键词
Autoantibodies; Acetylcholinesterase; Neuromuscular junction; Sympathetic system; Myasthenia gravis; ACETYLCHOLINESTERASE ANTIBODIES; NEUROMUSCULAR-TRANSMISSION; AUTOIMMUNE; THYROGLOBULIN; EXPRESSION; GENE; CHOLINESTERASES; OPHTHALMOPATHY; DISORDERS; JUNCTION;
D O I
10.1016/j.jneuroim.2009.11.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In MG, anti-AChR or anti-MuSK abs impair neuromuscular transmission. Partial inhibition of ACH can ameliorate symptoms, while a complete block causes a cholinergic blockade. We found anti-AChE abs in 115/240 MG patients, with no correlation with sex, age at onset, thymus pathology, presence of anti-AM or anti-MuSK antibodies. We found a correlation with the ocular form of the disease, and with milder forms of MG not requiring immunosuppressants; moreover, when we considered only those patients who were off AChEI therapy, we found that ocular patients were positive for anti-AChE abs, while generalized patients were negative. According to an experimental model, we hypothesize that anti-AChE abs could contribute to ptosis through an inhibition of the sympathetic innervation of the tarsal muscle. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:102 / 106
页数:5
相关论文
共 50 条
  • [31] Acetylcholinesterase inhibitor treatment for myasthenia gravis
    Mehndiratta, Man Mohan
    Pandey, Sanjay
    Kuntzer, Thierry
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
  • [32] Ocular aspects of myasthenia gravis
    Barton, JJS
    Fouladvand, M
    SEMINARS IN NEUROLOGY, 2000, 20 (01) : 7 - 20
  • [33] Pediatric Ocular Myasthenia Gravis
    Kristen Fisher
    Veeral Shah
    Current Treatment Options in Neurology, 2019, 21
  • [34] Controversies in Ocular Myasthenia Gravis
    Evoli, Amelia
    Iorio, Raffaele
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [35] Treatment of Ocular Myasthenia Gravis
    Cornblath, Wayne T.
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2018, 7 (04): : 257 - 259
  • [36] Thymectomy in ocular myasthenia gravis
    Lucchi, M
    Mussi, A
    Ricciardi, R
    Angeletti, CA
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (03): : 740 - 741
  • [37] Update on Ocular Myasthenia Gravis
    Smith, Stacy V.
    Lee, Andrew G.
    NEUROLOGIC CLINICS, 2017, 35 (01) : 115 - +
  • [38] Update on Ocular Myasthenia Gravis
    O'Hare, Meabh
    Doughty, Christopher
    SEMINARS IN NEUROLOGY, 2019, 39 (06) : 749 - 760
  • [39] OCULAR MYASTHENIA-GRAVIS
    VANDALEN, JTW
    VANMOURIKNOORDENBOS, AM
    OPHTHALMOLOGICA, 1985, 190 (03) : 176 - 176
  • [40] Treatment of Ocular Myasthenia Gravis
    Scott R. Haines
    Matthew J. Thurtell
    Current Treatment Options in Neurology, 2012, 14 : 103 - 112